Read + Share
Cramer P, Tausch E, von Tresckow J, Giza A, et al. Durable remissions following combined targeted therapy in patients with CLL
harboring TP53 deletions and/or mutations. Blood 2021;138:1805-1816.
PMID: 34086865
|
 |
|
Cramer P, Tausch E, von Tresckow J, Giza A, et al. Durable remissions following combined targeted therapy in patients with CLL
harboring TP53 deletions and/or mutations. Blood 2021;138:1805-1816.
PMID: 34086865
|
|
|
|